SEC Tracker
Get the app

Akanda AKAN

Akanda (AKAN) filed a Form 6-K to report on its recent acquisition of a leading European cannabis company. This strategic move expands Akanda's footprint and product portfolio in the rapidly growing European medical cannabis market, positioning the company for accelerated growth and increased market share. Investors should closely monitor Akanda's progress as it executes on this transformative acquisition.

Foreign issuer report

Form
6-K
Filed
Importance
Routine

Open in the appGet the appView on EDGAR

Get an email when Akanda files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2833 and related industry codes: the same peer list as the financial tables.

  1. Alterola Biotech ABTI
  2. Adia Nutrition ADIA public float $6M, Jun 30, 2025
  3. American Cannabis Company AMMJ
  4. Target Group CBDY public float $5M, Jun 30, 2025
  5. China Foods Holdings CFOO public float $864K, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.